Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Change in Account Payables (2016 - 2017)

Updated

Savara (SVRA) reported Change in Account Payables of -$127,000 for Q1 2017, compared with -$776,000 a year earlier.

Analysis

Savara (SVRA) Change in Account Payables (2016 - 2017) Analysis & Trends

For FY2016, Savara posted Change in Account Payables of -$1.97 million.

  • By year, Change in Account Payables came in at $1.23 million in FY2015 (+203.0%) and $406,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -127,000.00
Mar 31, 2016 -776,000.00
API Access

Savara Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SVRA&period=max&api_key=YOUR_API_KEY